Form 4 for JAGX Jaguar Health, Inc.
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-17 · accession 0001104659-23-062747 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-19 | 2023-05-17 | JAGX | Siegel Jonathan B. | Dir | M - OptEx | — | +1,145 | 1,306 | +711% | — |
| D | 2023-05-19 | 2023-05-17 | JAGX | Siegel Jonathan B. | Dir | M - OptEx | $0.00 | -1,145 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | M | A | 1,145 | — | 1,306 | D | — | — | (F2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F3) On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. |
| 2 | Derivative | Restricted stock units | 2023-05-17 | M | D | 1,145 | $0.00 | 0 | D | — · — to — | 1,145 Common Stock | (F1) Granted pursuant to the issuer's 2014 Stock Incentive Plan. (F4) The restricted stock units were previously reported as covering 85,900 shares, but were adjusted to reflect the January 2023 Reverse Stock Split. Such restricted stock units were granted on March 28, 2022 and vested in full on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice. (F2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F3) On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. |